M. Radvan

发表

Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?

P. Svoboda, P. Scheer, I. Kantorová, 2007, Hepato-gastroenterology.

Přehled kardiovaskulárního postižení u nemocných s covid-19

P. Kala, M. Radvan, L. Koc, 2021 .

Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial.

P. Svoboda, I. Kantorová, P. Scheer, 2009, Hepato-gastroenterology.

Local thrombolysis for deep vein thrombosis: why, for whom and how?

P. Kala, J. Hustý, M. Radvan, 2020, Vnitrni lekarstvi.

Acute purulent pericarditis caused by Clostridium septicum

P. Nemec, T. Freiberger, M. Radvan, 2018, Cor et Vasa.

COVID-19 vaccine booster significantly decreases the risk of intensive care unit hospitalization in heart failure patients during the Omicron variant wave: A population-based study

L. Dušek, P. Kala, Jirí Jarkovský, 2022, Frontiers in Cardiovascular Medicine.

Terlipressin in the treatment of late phase catecholamine-resistant septic shock.

P. Svoboda, I. Kantorová, P. Scheer, 2012, Hepato-gastroenterology.

Contrast-induced acute kidney injury and its contemporary prevention

M. Hudec, P. Kala, R. Štípal, 2022, Frontiers in Cardiovascular Medicine.

Our experience with transoral incisionless plication of gastroesophageal reflux disease: NOTES procedure.

P. Svoboda, I. Kantorová, P. Scheer, 2011, Hepato-gastroenterology.

Follow-up care after COVID-19 and its related concerns.

P. Kala, M. Radvan, L. Koc, 2021, Vnitrni lekarstvi.

Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients.

P. Svoboda, P. Scheer, Jana Radvanová, 2009, Hepato-Gastroenterology.

Cardiac sequelae after COVID-19: Results of a 1-year follow-up study with echocardiography and biomarkers

P. Kala, J. Hořínková, R. Štěpánová, 2022, Frontiers in Cardiovascular Medicine.